Phenotyping PH in COPD is a major challenge in respiratory medicine. Grateful for the great collaboration with the Strasbourg team. Our study is now out in ERJ Open Research Pulmotension InsermU999 Société de Pneumologie de Langue Française (SPLF) HTaPFrance publications.ersnet.org/content/erjor/…

Honoured to have contributed to the global-first position statement on reducing cardiopulmonary risk in people with #COPD. Thank you for the opportunity, Prof Chris P Gale and John Hurst. #CVD #multimorbidity academic.oup.com/eurjpc/advance…

World first! MHRAgovuk approves the first pMDI for #COPD with a new propellant having near-zero global warning potential. pMDIs are essential medicines. Kudos to all involved. A good day for people living with COPD, and the 🌎. gov.uk/government/new…

#COPD

Managing cardiopulmonary risk in #COPD: expert insight & consensus hospitalhealthcare.com/clinical/respi…

Glad to have presented last week's Woolcock Institute of Medical Research Friday seminar about my innovative research program on managing #COPD in the context of #multimorbidity. The seminar recording is available here: macquarie.zoom.us/rec/play/bIYAC… #publichealth #primaryhealthcare

Come and take me on in our #ATS2025 #COPD bike challenge. Can you beat the #copdathlete Find me at the Inogen booth #326

A landmark moment for global lung health! #WHA78 ERS and @europeanlung applaud adoption of historic lung health resolution on “Promoting and prioritizing an integrated lung health approach” at the 78th World Health Assembly. Read more: bit.ly/4dvVHa9

Workplaces where people are engaged do significantly better in productivity & performance. If we want to build better staff engagement, we need more conversations, not "engagement campaigns". Too often, leaders who want to improve staff engagement build “campaign-style”

The International Cardiovascular & Respiratory Alliance, ICRA, is a global group that I founded & co-chair with Prof M Bhutani. We represent healthcare professionals, academics & patients from >40 countries. To join (free) email: [email protected]

#COPD & the Management of Cardiopulmonary Risk dovepress.com/chronic-obstru…

In theory, #DPP-1 inhibitors should work any neutrophilic #airway conditions such as #COPD. The key is finding the #neutrophilic #COPD patients.

🆕 The skin condition #panniculitis is a rare manifestation of #alpha1. The lack of evidence makes it difficult to treat, and those affected often experience diagnostic delay and significant symptoms. You can read more in this paper by Reem | ريم from my lab. Alpha-1 Foundation

Feeling of satisfaction completing the Gold Coast Marathon today with one of our children. I’ve now had the joy of doing an event with all four of them as well as one grandchild. Marathons are no longer about medals or times. It’s about the joy of the experience! #copd

Interventions for the management of concomitant COPD and hypertension: A systematic review journals.sagepub.com/doi/10.1177/26… via Prof Chris P Gale et al

The July issue of Respirology is now available online: onlinelibrary.wiley.com/toc/14401843/2…

📘 #APO Policy Brief: Ageing in Pacific Island Countries Pacific Island Countries (#PICs) are facing a fast-growing challenge — ageing populations with rising rates of multimorbidity and disability, particularly from noncommunicable diseases (#NCDs). This new brief highlights

World COPD Day, November 19, 2025 - The goal of this year’s campaign is to emphasize that shortness of breath is a symptom that should prompt patients and healthcare providers to consider a diagnosis of COPD.

After 9 years of work, our new ATS Blue Journal paper is out, showing that in utero maternal smoke leaves lasting scars on lung health, and identifies CC16 as the first reliable biomarker of lung health across the lifespan. #cureCOPD atsjournals.org/doi/abs/10.116…